GoodRx (Nasdaq: GDRX) announced it is working with ARS Pharmaceuticals to offer the lowest discounted cash price for neffy in ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS ...

The generic version ranges from $150 to $200 per GoodRx data. ARS Pharma announced that most patients with commercial ...

Last week the FDA approved Neffy, an epinephrine nasal spray, for use in emergency allergic reactions for kids and adults. Retired allergist at the Northwest Asthma & Allergy Center Paul Williams ...

Telehealth and discount medicines provider GoodRx has been ordered to pay a $1.5 million fine by the US authorities for sharing its customers' sensitive health information with other companies ...

Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal ...

George Hill has given his Hold rating due to a combination of factors that reflect GoodRx Holdings’ mixed performance and uncertain future prospects. In the second quarter, the company reported ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings ...

If you're one of the many Americans struggling to afford prescription medication, GoodRx's deal with Walgreens could help you save the next time you're at the pharmacy. Prices on nearly 200 ...

GoodRx Holdings Inc provides a platform that helps consumers in the United States save on prescription drugs. By offering a price comparison tool, GoodRx enables users to find the best prices for ...

Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma and Eric Karas, Chief Commercial Officer ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with ...